Measles is spreading across the U.S.
Children who haven't gotten the MMR vaccine are most at risk. The vaccine is the best way to protect yourself and loved ones. Measles: What to Know
This memo is to inform North Carolina Immunization Program (NCIP) providers of the availability of influenza vaccine and the ordering process for the 2025-2026 respiratory season. Please take time to carefully review this memo in full.
The purpose of this email is to remind VFC-enrolled providers that the monoclonal antibody product nirsevimab (trade name Beyfortus® manufactured by Sanofi) will be available for ordering on Friday, August 1, 2025.
We are writing to inform you of several changes to the Vaccines for Children (VFC) program policies that may affect your practice, effective July 1, 2025.
This email is to inform you of an important update to share regarding measles reporting, testing, and vaccination.